Pfizer Inc
NYSE:PFE

Watchlist Manager
Pfizer Inc Logo
Pfizer Inc
NYSE:PFE
Watchlist
Price: 23.93 USD -1.97% Market Closed
Market Cap: 135.7B USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+25%
Revenue
Forecast
N/A
Net Income
Forecast
N/A

Wall Street
Price Targets

PFE Price Targets Summary
Pfizer Inc

Wall Street analysts forecast PFE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PFE is 29.71 USD with a low forecast of 22.22 USD and a high forecast of 43.5 USD.

PFE Lowest Forecast
Wall Street Target
22.22 USD
7% Downside
PFE Average Forecast
Wall Street Target
29.71 USD
24% Upside
PFE Highest Forecast
Wall Street Target
43.5 USD
82% Upside
Lowest
Price Target
22.22 USD
7% Downside
Average
Price Target
29.71 USD
24% Upside
Highest
Price Target
43.5 USD
82% Upside
Pfizer Inc Competitors:
Price Targets
TERN
Terns Pharmaceuticals Inc
480% Upside
ANIP
ANI Pharmaceuticals Inc
17% Upside
C
000661
Changchun High & New Technology Industries Group Inc
24% Upside
6622
Zhaoke Ophthalmology Ltd
50% Upside
TERN
Terns Pharmaceuticals Inc
480% Upside
ANIP
ANI Pharmaceuticals Inc
17% Upside
C
000661
Changchun High & New Technology Industries Group Inc
24% Upside
6622
Zhaoke Ophthalmology Ltd
50% Upside
COPN
Cosmo Pharmaceuticals NV
106% Upside
H
3692
Hansoh Pharmaceutical Group Company Ltd
9% Upside
4578
Otsuka Holdings Co Ltd
25% Upside
NATCOPHARM
Natco Pharma Ltd
32% Upside

Revenue
Forecast

Revenue Estimate
Pfizer Inc

For the last 8 years the compound annual growth rate for Pfizer Inc's revenue is 2%. The projected CAGR for the next 3 years is -1%.

2%
Past Growth
-1%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Pfizer Inc

For the last 8 years the compound annual growth rate for Pfizer Inc's operating income is 1%. The projected CAGR for the next 3 years is 10%.

1%
Past Growth
10%
Estimated Growth
Estimates Accuracy
-22%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Pfizer Inc

For the last 8 years the compound annual growth rate for Pfizer Inc's net income is 1%. The projected CAGR for the next 3 years is 29%.

1%
Past Growth
29%
Estimated Growth
Estimates Accuracy
-35%
Average Miss
What are analyst estimates?

See Also

Summary
PFE intrinsic value, competitors valuation, and company profile.
DCF Valuation
PFE stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PFE stock valuation using valuation multiples.
Wall Street Estimates
PFE price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PFE stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PFE's stock price target?
Price Target
29.71 USD

According to Wall Street analysts, the average 1-year price target for PFE is 29.71 USD with a low forecast of 22.22 USD and a high forecast of 43.5 USD.

What is Pfizer Inc's Revenue forecast?
Projected CAGR
-1%

For the last 8 years the compound annual growth rate for Pfizer Inc's revenue is 2%. The projected CAGR for the next 3 years is -1%.

What is Pfizer Inc's Operating Income forecast?
Projected CAGR
10%

For the last 8 years the compound annual growth rate for Pfizer Inc's operating income is 1%. The projected CAGR for the next 3 years is 10%.

What is Pfizer Inc's Net Income forecast?
Projected CAGR
29%

For the last 8 years the compound annual growth rate for Pfizer Inc's net income is 1%. The projected CAGR for the next 3 years is 29%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 251,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.